Trade Mark Journal No.2026/026 26 June 2026
WO0000001921898 (42,44)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:31 March 2026
Date of designation in the UK:
31 March 2026
International priority date claimed: 1 October 2025
(European Union Intellectual Property Office (EUIPO))
(019255097)
- Class 42
- Medical research; laboratory services; medical research laboratory services; biomedical research services; blood analysis services; blood analysis services for scientific research purposes; biofluid analysis services; biofluid analysis services for scientific research purposes; development of software application solutions for collecting, measuring, analysing, monitoring and reporting health condition as well as physiological and biosignal data; consultancy relating to laboratory testing; rental of laboratory apparatus and instruments; information, consultancy and advisory services relating to all of the aforementioned services.
- Class 44
- Laboratory analysis services relating to the treatment of persons; blood test services; medical laboratory services for the analysis of blood and biofluid samples taken from patients; conducting screenings for disease risk factors; collection and preservation of human blood; providing medical information; preparation and processing of reports relating to health care and wellbeing (relating to health); providing medical information and health information to patients, consumers, and medical professionals by means of preparation of reports relating to health care matters; information, consultancy and advisory services relating to all of the aforementioned services.
Nightingale Health Oyj
Representative: PAPULA OY, Mechelininkatu 1 a, FI-00180 Helsinki, FINLAND